-
Deliverables From 10 Years' Implementation of a National Health Technology Assessment System: Outcomes Sustainability Efficiency, Access, and Equity
Sep 9, 2025, 16:22 PM -
Projected Public Health Benefits of Nirsevimab for RSV Prevention in Infants in Greece
Sep 9, 2025, 16:22 PM -
The Impact of Inhaler Technique on the Health Outcomes and Cost Among Adults With Asthma and Chronic Obstructive Pulmonary Disease in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Evaluating GenAI for HTA Analogue Analysis: Identifying Rare Disease Approvals With Surrogate Endpoints and Single-Arm Trials
Sep 9, 2025, 16:22 PM -
Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
From Data to Decisions: Enhancing Real-World Data Quality: A Survey of Health Data Producers in France
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis Of Migalastat Incorporation vs. Enzyme Replacement Therapies For Fabry Disease: Validation of a Cost-Assessment Tool In Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Patient Pathways to Accessing Unregistered Medicines in Low-Priority Launch Markets
Sep 9, 2025, 16:22 PM -
A Review of Information Uncertainty in Oncology Treatment Preferences
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Supportive Exercise Interventions for Colorectal Cancer Surgery: An Economic Evaluation of the PREPARE-ABC Multicenter, Randomized, Controlled Trial
Sep 9, 2025, 16:22 PM -
Disparities in Access to Gene Therapy in the European Union: Ethical and Regulatory Challenges
Sep 9, 2025, 16:22 PM -
Hidden Obesity and Treatment Gaps in Japan: A Real-World Data Analysis
Sep 9, 2025, 16:22 PM -
Real-World Evidence of Atezolizumab in Unresectable Recurrent NSCLC: Insights From Japan's Next-Generation Medical Infrastructure Act
Sep 9, 2025, 16:22 PM -
Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System
Sep 9, 2025, 16:22 PM -
Economic Burden of the Adverse Events During Treatment of Metastatic Breast Cancer (mBC) HR-/HER2+ Patients in the Brazilian Private Healthcare System
Sep 9, 2025, 16:22 PM -
Prediction of Query Outcomes in the Setting of Observational Studies
Sep 9, 2025, 16:22 PM -
An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Sep 9, 2025, 16:22 PM -
Pillcam COLON 2 for Investigation of the COLON Through Direct Visualization: A Systematic Review
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of STRIDE (Tremelimumab + Durvalumab) vs. Atezolizumab + Bevacizumab for Unresectable Hepatocellular Carcinoma: Qatari Payer and Societal Perspectives
Sep 9, 2025, 16:22 PM -
Comparative Cardiovascular Safety of Romosozumab and Denosumab in Osteoporosis Treatment: A Multinational Real-World Cohort Study
Sep 9, 2025, 16:22 PM
